(Est time: 0.5 hrs) This module provides an overview of the patient-centered approach to treating opioid use disorder with buprenorphine, the laws for prescribing buprenorphine, and the training requirement.
Goal: To introduce providers to office-based opioid treatment with buprenorphine, including its importance, effectiveness, approach, and training requirement.
Recognize the need for opioid use disorder treatment given its prevalence
Apply a patient-centered approach in a buprenorphine practice
Describe buprenorphine's status as a controlled substance and the laws governing the prescribing of this medication
Describe the requirements to receive a waiver to prescribe buprenorphine
Explain the process of becoming certified to prescribe buprenorphine for patients with opioid use disorder
(Est time: 1 hr) This module describes how to screen for opioid use disorder and other substance use disorders and utilize communication skills for interacting with patients in a buprenorphine practice.
Goal: To prepare providers to screen for and diagnose opioid use disorder and motivate patients to change.
Use motivational interviewing skills to optimize patient communication in a buprenorphine practice
Screen for opioid use disorder through patient interviews and use of standardized screening instruments
Assess patients for signs and symptoms of opioid use disorder
Diagnose patients with opioid use disorder using current DSM criteria
(Est time: 1 hr) This module describes adaptations that are needed in a buprenorphine practice to meet the needs of patient subpopulations, including patients transferring from methadone to buprenorphine.
Goal: To prepare providers to adapt a buprenorphine practice to the needs of patient subpopulations, including patients transferring from methadone to buprenorphine.
Modify buprenorphine treatment as needed for patients who are transferring from methadone treatment to buprenorphine
Recognize, anticipate, and address complications of buprenorphine treatment in patients using multiple other substances
Recognize the patient subpopulations having additional requirements for treatment modifications in office-based opioid treatment
Adapt buprenorphine treatment to the needs of patient subpopulations having additional requirements
This is an 8-hour-equivalent program. You must complete all 10 modules in an appropriate amount of time to meet the requirement of the DATA 2000 law. Please pace yourself to address the material completely.
Development of this website was funded entirely by grant #R44DA12066 and contract #HHSN271200655304C from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc. No commercial support is received.
Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Interactive training is delivered by the CTI Learning Ecosystem and our FAOS DLearning Drupal modules and requires IE 10/ higher, Firefox, Chrome or Safari.
Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.
developed & maintained by
A member of The Clinical Tools, Inc (CTI) Addiction Training Group: SBIRT Training | Opioid Risk Reduction | Buprenorphine Training
This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions.